Kuros Biosciences AG (SWX:KURN)
21.64
-0.28 (-1.28%)
Apr 24, 2025, 3:44 PM CET
Kuros Biosciences AG Revenue
In the year 2024, Kuros Biosciences AG had annual revenue of 75.56M CHF with 125.11% growth.
Revenue
75.56M
Revenue Growth
+179.89%
P/S Ratio
11.01
Revenue / Employee
619.30K
Employees
122
Market Cap
832.09M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 75.56M | 41.99M | 125.11% |
Dec 31, 2023 | 33.56M | 15.58M | 86.61% |
Dec 31, 2022 | 17.99M | 4.17M | 30.19% |
Dec 31, 2021 | 13.82M | 9.78M | 242.04% |
Dec 31, 2020 | 4.04M | 1.48M | 57.71% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 62.40B |
Novartis AG | 46.87B |
Lonza Group AG | 6.57B |
Alcon | 8.98B |
Galderma Group AG | 4.02B |
Straumann Holding AG | 2.50B |
Sonova Holding AG | 3.71B |
Sandoz Group AG | 9.41B |